AP
ALAB icon

Atwood & Palmer’s Astera Labs ALAB Stock Holding History

Atwood & Palmer’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-5
Closed -$2.42K – 522
2026
Q2 		$2.42K Hold
5
– – ﹤0.01% 431
2026
Q1 		$548 Buy
+5
New +$712 ﹤0.01% 504

Other funds holding ALAB

OGC
Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return
IFS
Integrated Financial Solutions Reston, Virginia $195M AUM 46.13% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CCA
Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $937M AUM 18.56% 1-Year Est. Return

Atwood & Palmer's ALAB Position: Q3 2026 in Review

Atwood & Palmer sold out of Astera Labs (ALAB) in Q3 2026, closing a stake of 5 shares — an estimated $2.42K sold.

Atwood & Palmer first reported a position in ALAB in Q1 2026 and held it in 2 quarters. The position peaked at $2.42K in Q2 2026. 27 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Atwood & Palmer reported no remaining Astera Labs position as of Q3 2026 after selling out during the quarter.
  • Atwood & Palmer sold 5 Astera Labs shares in Q3 2026, an estimated $2.42K.
  • Atwood & Palmer first reported a position in Astera Labs in Q1 2026 and held it in 2 quarters.
  • Atwood & Palmer's Astera Labs position peaked at $2.42K in Q2 2026.
  • 27 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Atwood & Palmer's 13F filing for Q3 2026, filed 8 Oct 2026.